697 related articles for article (PubMed ID: 2903934)
1. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
Brook I
J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
[TBL] [Abstract][Full Text] [Related]
2. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
Brook I
Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Brook I
J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
[TBL] [Abstract][Full Text] [Related]
4. Bacteraemia and seeding of capsulate Bacteroides spp. and anaerobic cocci.
Brook I
J Med Microbiol; 1987 Feb; 23(1):61-7. PubMed ID: 3820272
[TBL] [Abstract][Full Text] [Related]
5. The relationship between Fusobacterium species and other flora in mixed infection.
Brook I; Walker RI
J Med Microbiol; 1986 Mar; 21(2):93-100. PubMed ID: 2936888
[TBL] [Abstract][Full Text] [Related]
6. In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities.
Brook I
Antimicrob Agents Chemother; 1993 May; 37(5):997-1000. PubMed ID: 8517727
[TBL] [Abstract][Full Text] [Related]
7. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
Brook I; Ledney GD
J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
[TBL] [Abstract][Full Text] [Related]
8. Metronidazole and spiramycin in abscesses caused by Bacteroides spp. and Staphylococcus aureus in mice.
Brook I
J Antimicrob Chemother; 1987 Nov; 20(5):713-8. PubMed ID: 3429373
[TBL] [Abstract][Full Text] [Related]
9. Significance of encapsulated Bacteroides melaninogenicus and Bacteroides fragilis groups in mixed infections.
Brook I; Walker RI
Infect Immun; 1984 Apr; 44(1):12-5. PubMed ID: 6142862
[TBL] [Abstract][Full Text] [Related]
10. The effect of antimicrobial therapy on mixed infections with Bacteroides species. Is eradication of the anaerobes important?
Brook I
J Infect; 1991 Jan; 22(1):27-35. PubMed ID: 2002230
[TBL] [Abstract][Full Text] [Related]
11. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
Brook I; Coolbaugh JC; Walker RI; Weiss E
Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
[TBL] [Abstract][Full Text] [Related]
12. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
[TBL] [Abstract][Full Text] [Related]
13. Synergy between spiramycin and metronidazole in the treatment of polymicrobial infections.
Brook I
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():77-85. PubMed ID: 3141350
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacies of ticarcillin, ticarcillin/clavulanic acid, piperacillin and cefoxitin against polymicrobial infections in mice caused by Escherichia coli and Bacteroides fragilis.
Beale AS; Gisby J
Infection; 1991; 19(2):101-5. PubMed ID: 2050417
[TBL] [Abstract][Full Text] [Related]
15. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
Am Surg; 1995 Aug; 61(8):726-31. PubMed ID: 7618816
[TBL] [Abstract][Full Text] [Related]
16. Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice.
Brook I
Antimicrob Agents Chemother; 1993 Jul; 37(7):1531-5. PubMed ID: 8363386
[TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
Rotstein OD; Kao J; Houston K
J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
[TBL] [Abstract][Full Text] [Related]
19. Effect of Streptococcus faecalis on the growth of Bacteroides species and anaerobic cocci in mixed infection.
Brook I
Surgery; 1988 Jan; 103(1):107-10. PubMed ID: 3122348
[TBL] [Abstract][Full Text] [Related]
20. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
Wells CL; Arland LA; Simmons RL; Rotstein OD
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
